Streptococcus Group B antibody

Catalog No. ABIN125933

The Mouse Monoclonal anti-Streptococcus Group B antibody has been validated for IF, AGG, H, IHC (fro) and IHC (p). It is suitable to detect Streptococcus Group B in samples from Streptococcus.

Quick Overview for Streptococcus Group B antibody (ABIN125933)

Target: Streptococcus Group B

Reactivity: Streptococcus

Host: Mouse

Clonality: Monoclonal

Conjugate: This Streptococcus Group B antibody is un-conjugated

Application: Immunofluorescence (IF), Aggregation (AGG), Haemagglutination (H), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: 1F9

Product Details anti-Streptococcus Group B Antibody

Purification: Protein A Affinity Chromatography

Immunogen: Group B Streptococcus

Isotype: IgG2b

Application Details

Application Notes: Immunofluorescence (1: 20). Immunohistochemistry on frozen and paraffin embedded material (formaldehyde ormethacarn fixation). Agglutination.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: PBS containing 0.5 % BSA as a stabilizer and 0.09 % Sodium Azide as preservative

Preservative: Sodium azide

Precaution of Use: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Avoid repeated freezing and thawing.

Storage: 4 °C/-20 °C

Storage Comment: Store the antibody at 2-8 °C for one month or (in aliquots) at -20 °C for longer. Do not freeze working dilutions

Target Details for Streptococcus Group B

Target: Streptococcus Group B

Target Type: Bacteria

Background: Streptococci form part of the normal human flora that resides on the skin, and can also colonise the respiratory, gastrointestinal, and genitourinary tracts. Streptococci can cause a range of diseases, from the less serious but common sore throats and skin infections to life threatening conditions such as necrotising fasciitis. Different streptococcal species are involved in human disease, broadly categorised as pus forming or pyogenic streptococci, non pus forming or non pyogenic streptococci, and Streptococcus pneumoniae. Streptococci are classified into Lancefield serotypes by their cell wall polysaccharide antigens. Group A are primarily pathogens. Group B streptococci (including Streptococcus agalactiae) are the leading bacterial causes of human neonatal illness and death causing opportunistic invasive disease in pregnant women such as preterm labour, membrane rupture and urinary tract infections and sepsis and meningitis in newborns.